Opportunities in Outpatient Care

Outpatient Care Clinical Trial

Official title:

Characterizing and Quantifying Challenges and Opportunities in Outpatient Care

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03163225
• Other study ID #: 1050460
• Status: Completed
• Start date: September 1, 2017
• Est. completion date: October 31, 2017

Study information

• Verified date: August 2018
• Source: Intermountain Health Care, Inc.
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this research study is to determine whether there are things that Intermountain can do to break down barriers to helping patients see their primary doctors or other outpatient clinics. To do this we will develop and test a classification scheme to help us understand how we might reduce some avoidable emergency department and InstaCare visits.

Description:

The study will develop a first-pass taxonomy that classifies the causes and effects of challenges and opportunities of outpatient care leading to potentially avoidable ED and urgent care center visits.

The study will quantify the proportion of ED and urgent care center visits that result from a challenge or opportunity in outpatient care and classify the causes and outcomes according to the taxonomy. It will also define the 30 and 90 day episode costs of ED and urgent care center visits associated with a challenges and opportunities of outpatient care beginning the day of the ED or urgent care center visit.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1027
• Est. completion date: October 31, 2017
• Est. primary completion date: October 31, 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 7 Years and older

Eligibility

Inclusion Criteria:

• All Emergency Department/IC patients who can consent, including children.

Exclusion Criteria:

• Unable to give consent

• Prisoners

Related Conditions & MeSH terms

• Outpatient Care

Locations

Country	Name	City	State
United States	Cottonwood InstaCare	Murray	Utah
United States	Intermountain Medical Center	Murray	Utah
United States	Riverton Hospital	Riverton	Utah
United States	Southridge InstaCare	Riverton	Utah
United States	LDS Hospital	Salt Lake City	Utah
United States	Memorial InstaCare	Salt Lake City	Utah
United States	Salt Lake City InstaCare	Salt Lake City	Utah
United States	Alta View Hospital	Sandy	Utah
United States	Sandy InstaCare	Sandy	Utah

Sponsors (1)

Lead Sponsor	Collaborator
Intermountain Health Care, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Incidence rate of avoidable ED visits due to a "missed" opportunity in outpatient care	The proportion of ED visits during the selected shifts that were deemed to be potentially avoidable according to the developed taxonomy	1 Day
Primary	Incidence rate of avoidable InstaCare visits due to a "missed" opportunity in outpatient care	The proportion of Instacare visits during the selected shifts that were deemed to be potentially avoidable according to the developed taxonomy	1 Day
Secondary	Patient Disposition Status from the ED	Disposition status from after the ED visit, collected from the medical record. Status will be one of the following: admitted, observation, transfer to facility, discharged, deceased.	1 Day
Secondary	Patient Disposition Status from the InstaCare	Disposition status from after the Instacare visit, collected from the medical record. Status may be admitted, observation, transfer to facility, discharged, or deceased.	1 Day
Secondary	Length of stay for admitted patients	Length in stay by days in study patients admitted to the hospital	Up to 30 days
Secondary	Harms to patients due to the missed opportunities in outpatient care.	Categorization of the "harms" on patients due to the missed opportunities in outpatient care using NCC-MERP categorizations	90 days
Secondary	30 day episode costs	All attributable healthcare costs accrued to study patients from the date of visit to +30 days.	30 days
Secondary	90 day episode costs	All attributable healthcare costs accrued to study patients from the date of visit to +90 days.	90 days